Community/Retail

Two new analyses of more than 60,000 patients found dabigatran etexilate was linked to fewer major bleeds and strokes than warfarin.

A former pharmacy technician thought the prescription pill records she was finagling were better shred than read.

A Maryland pharmacist has been charged with the theft of more than 7300 tablets of hydrocodone, a painkiller found in Vicodin and Lortab.

Expanding upon efforts to implement the federal Drug Quality and Security Act enacted 1 year ago, the FDA today released 3 policy documents that assist companies that compound sterile drugs with registering as outsourcing facilities.

Based on patient response rates and efficacy, olanzapine/fluoxetine is the ideal first-line treatment for depression caused by bipolar disorder.

Bayer is expanding its aid donations for Ebola patients in Liberia and Sierra Leone.

Forever Beautiful Bee Pollen and Forever Beautiful Infinity were found to be forever dangerous to consumers.

Several provisions of the Affordable Care Act intend to improve smoking cessation rates by increasing insurance coverage for effective interventions.

During cold and flu season, working women turn to pharmacies whenever symptoms appear, according to the results of a recent study conducted by Workplace Impact.

Sanofi and Regeneron Pharmaceutics, Inc, have convinced the FDA that their atopic dermatitis treatment works well enough to undergo accelerated development and regulatory review.

There are hundreds of pharmacists on Twitter, but who should you follow? Here, I have listed the top 10 pharmacist influencers, in no particular order.

Children exposed to antibiotics during the second or third trimester of pregnancy have an 84% higher risk of being obese at age 7 compared with children who were not exposed to the drugs in utero, according to new research published in the Journal of Obesity.

The Pacific American Pharmacists Association-Academy of Student Pharmacists (APhA-ASP) kicked off American Pharmacists Month with a health fair at Midtown Farmers Market in Sacramento.

The FDA today approved hydrocodone bitartrate, an extended-release opioid analgesic for treating severe pain that requires daily long-term opioid treatment and for which other treatment options are inadequate.

A pharmacist testified before a Senate subcommittee today that unprecedented price hikes for formerly inexpensive generic prescription drugs are "wreaking havoc" on the health care system while jeopardizing the viability of community pharmacies.

Based on its recent analysis of the medication management solutions market, Frost & Sullivan recognizes Codonics with the 2014 North America Frost & Sullivan Award for Customer Value Leadership.

CVS Health today announced that the company and its foundation has committed to invest more than $1 million in grants to support tobacco cessation and prevention programs. The grants will be distributed to leading health care and community partners working to promote tobacco-free communities, programs that help people kick the habit and help those who don't smoke to never start. Among the awards are funds to support quit lines operated by National Jewish Health and the American Lung Association, which also partners with CVS Health on the LUNG FORCE initiative to fight cancer. These investments also build on the partnership developed between CVS Health and the American Cancer Society. With this announcement, CVS Health joins the American Cancer Society and advocates across the country in recognizing the Great American Smokeout.

MinuteClinic has opened New Mexico's first retail medical clinics inside three CVS/pharmacy stores in Albuquerque and one in Rio Rancho. MinuteClinic is the retail medical clinic of CVS Health and the largest and fastest growing provider of store-based clinics with locations in 31 states and the District of Columbia.

Progress in stopping the spread of the Ebola has been achieved in 2 West African countries, though new cases of the virus are increasing in a third.

The prices for brand-name prescription medications commonly used by older adults increased by an approximate average of 13% last year, more than 8 times faster than the general inflation rate.

On the heels of the FDA approval of paliperidone palmitate as either a monotherapy or adjunctive therapy for schizoaffective disorder, Janssen Pharmaceuticals, Inc, has submitted a new drug application for the medication's use as a 3-month atypical antipsychotic treatment for schizophrenia in adults.

A diverse collective of health care advocacy groups, patient organizations, industry representatives and other stakeholders today announced they have established the Alliance for Balanced Pain Management to support appropriate access to integrated pain management and responsible use of prescription pain medicines with an aim to reduce abuse. AfBPM will work collaboratively to educate, support and advocate on behalf of people affected by pain, both acute and chronic.

After the Drug Enforcement Administration revoked the Tampa-based pharmacy's registration to sell controlled substances and seized its drugs, the company fought back with a lawsuit.

Boehringer Ingelheim announced today that it received a perfect score of 100 percent on the 2015 Corporate Equality Index.

Fewer brand-name drugs are prescribed when their generic equivalents are displayed in the electronic health record first.

A new liquid drug formulation from Teva Pharmaceutical Industries Ltd. will allow some cancer patients to see their therapy administered faster.

The first FDA-approved "smart pill" documents medication adherence and physiologic response.

People whose jobs require more complex work with other people, such as social workers and lawyers, or with data, like architects or graphic designers, may end up having longer-lasting memory and thinking abilities compared to people who do less complex work.

Generics saved $239 billion in 2013 (a 14% increase in savings from 2012) and more than $1.46 trillion over the recent decade. Further, the Express Scripts 2013 Drug Trend Report issued in 2014 shows that since 2008, the price of brand drugs has almost doubled, but the price of generic drugs has been cut roughly in half.